Next, we compared the isotype of class-switched spike-specific B cells between patients who recovered from non-severe and severe COVID-19 by categorizing spike-specific antigen-experienced B cells based on IgM, IgG, or IgA expression. This evidence concerns the gene CD79A and COVID-19.